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There are few data for hormonal levels and testis structure 
and function during postnatal development in rats neonatally 
treated with monosodium L-glutamate (MSG). In our study, 
newborn male pups were ip injected with MSG (4 mg/g body 
weight) every 2 d up to 10 d of age and investigated at pre­
pubertal and adult ages. Plasma levels of leptin, LH, FSH, 
prolactin, testosterone (T), corticosterone, and free T4 (FT4) 
were measured. MSG rats displayed elevated circulating lev­
els of corticosterone and hyperadiposity/hyperleptinemia, re­
gardless of the age examined; conversely, circulating prolac­
tin levels were not affected. Moreover, prepubertal MSG rats 
revealed a significant CP < 0.05) reduction in testis weight and 
the number of Sertoli (SC) and Leydig cells per testis. Leptin 
plasma levels were severalfold higher (2.41 vs. 8.07; P < 0.05) 
in prepubertal MSG rats, and these animals displayed plasma
THE ADIPOSE TISSUE-derived peptide, leptin, has been shown to be important for the regulation of food intake, energy metabolism, and reproductive function (1-4), regard­
less of the sex of individuals. This peptide is the ob gene 
product controlled by TNFa and is composed of 145 amino 
acid residues and molecular mass of approximately 16 kDa 
(5). Several reports described leptin as being involved in 
normal sexual maturation and reproductive process (1,6). In 
addition, it has been shown that leptin is a metabolic key 
regulator of reproductive function and that this peptide is a 
signal between the nutritional status and reproduction (4).
The leptin receptor is expressed, at least, in six isoforms 
(a-f) arising from mRNA splice variants (7). The biologically 
active variant of the leptin receptor (Ob-Rb) is localized in the 
arcuate (ARC) and ventromedial nuclei of the hypothalamus. 
Also, the expression and localization of leptin receptor have 
been shown in gonadotrope (8), Leydig (9), and male germ 
(10) cells. In the testis, it was showed that leptin crosses the 
murine blood-testis barrier by a nonsaturable process (11). 
However, other authors found Ob-R in this organ and that 
the Ob-Rb isoform is the predominant variant expressed (12).
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LH, FSH, T, and FT4 levels significantly decreased (P < 0.05). 
Taken together, these data indicate that testis development, 
as well as SC and Leydig cell proliferation, were disturbed in 
prepubertal MSG rats. Adult MSG rats also displayed signif­
icantly higher leptin plasma levels (7.26 vs. 27.04; P < 0.05) and 
lower (P < 0.05) LH and FSH plasma levels. However, T and 
FT4 plasma levels were normal, and no apparent alterations 
were observed in testis structure of MSG rats. Only the num­
ber of SCs per testis was significantly (P < 0.05) reduced in the 
adult MSG rats. In conclusion, although early installed hy- 
peradipose/hyperleptinemia phenotype was probably respon­
sible for the reproductive axis damages in MSG animals, it 
remains to be investigated whether this condition is the main 
factor for hypothalamus-pituitary-gonadal axis dysfunction 
in MSG rats. (Endocrinology 147: 1556-1563, 2006)
Also, it has been shown that Ob-Rf is a soluble isoform that 
serves as a circulating leptin-binding protein (13), and a 
saturable transport system for leptin was shown at the cen­
tral nervous system level (14).
It has been proposed that a specific and narrow range of 
leptin concentration is necessary to maintain a normal re­
productive function; and levels below or above these thresh­
olds are critical for the influence of this peptide on the hy- 
pothalamus-pituitary-gonadal (HPG) axis function (3, 4). 
Also, although male mice deficient in leptin (pb/ob) are in­
fertile, this condition could be reverted by leptin adminis­
tration (15).
The neonatal administration of monosodium L-glutamate 
(MSG) in rodents damages the ARC, thus resulting in a 
syndrome characterized by stunted growth, hyperadiposity, 
and hypogonadism during adulthood (16, 17). However, to 
our knowledge there are only few data in the literature re­
garding the plasma levels of the several hormones secreted 
by gonadotropes in MSG-damaged prepubertal and adult 
rats (18). Also, no data related to changes in the structure and 
function of the male reproductive tract during postnatal de­
velopment have been reported in MSG-lesioned rats. A re­
cent study from our laboratories has shown that the endog­
enous hyperleptinemia, caused by MSG treatment, is able to 
modify testicular steroidogenic activity and the expression of 
Leydig cell leptin receptor in adult rats (19). Thus, although 
the neurotoxic effects of MSG are relatively well studied, to 
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ing a more detailed investigation on the impact of neonatal 
MSG treatment on HPG axis development, namely when 
evaluation is performed from parameters related to testis 
structure and activity, in association with several markers of 
reproductive function.
Materials and Methods
Animals, treatment, and tissue preparation
Adult male (350-450 g) and female (240-280 g) Sprague Dawley rats 
were allowed to mate in colony cages in a light (12-h light cycle, lights 
on at 0700 h)- and temperature (20-22 C)-controlled room and were fed 
standard food pellets and water ad libitum. Pregnant female rats were 
placed in clear individual plastic cages.
Male pups, 2 d after birth, were injected ip with 4 mg/g body weight 
MSG (Merck, Darmstadt, Germany) dissolved in 0.9% NaCl or the same 
volume of 10% NaCl (control) every 2 d up to 10 d of age (19). These rats 
were weaned at 21 d of age, and male rats were then killed at the age 
of 1 or 4 months (n = 9-10 rats/group per age). All procedures per­
formed followed approved National Institutes of Health Guidelines for 
Care and Use of Experimental Animals.
Blood samples were collected by cardiac puncture before perfusion 
and plasma samples were kept frozen (—20 C) until measurement of 
different hormones [leptin, FSH, LH, prolactin, corticosterone, testos­
terone (T), and free T4 (FT4)]. Testis tissue processing was performed 
according to Russell et al. (20). In brief, 15 min before the initiation of 
perfusion for tissue fixation, rats were injected ip with heparin at a dose 
of 130 IU/kgbody weight. Anesthetized (ketamine-xylazine) rats were 
perfused through the left ventricle with 0.9% NaCl (~5 min) to clear 
blood vessels. After clearance of vessels, a two-way valve apparatus was 
used to introduce 4% glutaraldehyde in phosphate buffer 0.05 M (pH 7.4) 
without removal of the needle. Animals were perfused for 25-30 min, 
whereupon testes, epididymides, seminal vesicle plus coagulating gland 
and adrenal glands were removed and weighed. To perform light mi­
croscopic investigations, testis fragments were routinely processed and 
embedded in plastic (glycol methacrylate). Subsequently sections of 4 
|.im in thickness were obtained and stained with toluidine blue. Imme­
diately after the animals were killed, total fat (the sum of omental, 
epididymal and retroperitoneal) pads, from rats of both groups/ages 
were dissected and weighed.
Hormonal measurements
Plasma leptin concentrations were determined by a specific RIA pre­
viously developed and validated for rat leptin in our laboratory (21). 
Briefly, synthetic murine leptin (PrePro Tech, Inc., Rocky Hill, NJ) was 
used for both labeled peptide and standards as well as for the devel­
opment of antileptin serum. Leptin was labeled with 125I-Na (specific 
activity 15 Ci/mmol; Amersham Pharmacia Biotech, Little Chalfont, 
UK) by the chloramine-T method and purified by elution after loading 
the radioiodination mixture from a Sephacryl S-300 (Sigma Chemical 
Co., St. Louis, MO) (1.5 x 60 cm) column equilibrated with sodium 
phosphate (0.05 m)-BSA (2 g/liter)-sodium azide (10 mg/liter) solution 
(pH 7.4). The antileptin serum was developed by rabbit immunization 
with murine leptin (PrePro Tech) coupled to BSA. The detection range 
of the standard curve was 0.4-50 ng/ml. Unknowns or standards (200 
yil) were incubated overnight at room temperature in the presence of 50 
/.d of antileptin rabbit serum (final dilution 1:15,000) and 50 yd (—30,000 
cpm) of tracer. Separation of bound and free fractions was achieved by 
addition, first, of 200 pl normal saline solution containing antirabbit 
y-globulin and then 500 pl polyethylene glycol 6000 (10% wt/vol, in 
normal saline) solution and then incubated for 30 min at 4 C until 
centrifuged (40 min at 4 C, 4000 rpm). Supernatants were aspirated and 
bound radioactivity was counted. The assay displayed 2% and zero 
cross-reactivity with human leptin and mouse/rat anterior pituitary 
(LH, FSH, GH, prolactin) hormones, respectively. The within-assay and 
interassay coefficients of variation were 5-8 and 10-13%, respectively.
Serum levels of LH, FSH, and prolactin were determined by double­
antibody RIAs, as previously described (22). Results are expressed in 
terms of the reference preparations (rat LH-RP3, FSH-RP-2, and PRL- 
RP-3), supplied by the National Institute of Diabetes and Digestive and 
Kidney Diseases (Bethesda, MD). Sensitivity for the assays were: LH, 
0.024 ng/tube; FSH, 0.10 ng/tube; and prolactin, 0.05 ng/tube. The 
within-assay and interassay coefficients of variation were less than 8 and 
13%, respectively, regardless of the assay. T levels in plasma was mea­
sured by RIA using testosterone [1,2-3H (N), 60 Ci/mmol| from NEN 
Life Science Products (Boston, MA) and a specific antibody from Im­
munotech Diagnostic (Montréal, Canada), as previously described and 
validated (23). The sensitivity of the testosterone assay was 12.5 pg/ml. 
The within-assay and interassay coefficients of variation were less than 
12%. Plasma concentrations of corticosterone were evaluated by a spe­
cific RIA earlier reported (21); the standard curve ranged between 1 and 
250 pig/dl, and intra- and interassay coefficients of variation were 5 and 
9%, respectively. FT4 levels in serum were also assayed by RIA using a 
kit from Diagnostic Product Corp. (Los Angeles, CA) and validated in 
our laboratory for rat plasma samples. The within-assay and interassay 
coefficients of variation were 4.5 and 8%, respectively.
Testis histology and morphometry
Qualitative histological analysis of the testis was performed carefully 
to verify the most advanced germ cell type present in the seminiferous 
epithelium of each 30-d-old animal, according to the criteria described 
by Russell et al. (20) to characterize rat germ cell association through the 
acrosomic system method. Apoptotic germ cells were characterized as 
cells with dark nucleus and cytoplasm and shrunk plasma membrane; 
this germ cells apoptotic characteristics are easily recognizable in testis 
tissue fixed with glutaraldehyde and embedded in plastic resin, and this 
methodological approach is fully validated in the literature (20, 24).
The tubular diameter was measured at X200 magnification using an 
ocular micrometer calibrated with a stage micrometer. At least 30 tu­
bular profiles that were round or nearly round were chosen randomly 
and measured for each animal. The volume densities of various testic­
ular tissue components were determined by light microscopy using a 
441-intersection grid placed in the ocular of the light microscope. Fifteen 
fields chosen randomly (6615 points) were scored for each animal at 
X400 magnification. Artifacts were rarely seen and were not considered 
in the total number of points used to obtain volume densities. Points 
were classified as one of the following: seminiferous tubule, comprising 
tunica propria, epithelium, and lumen; apoptotic germ cells; Leydig cell; 
blood and lymphatic vessels; and connective tissue. The volume of each 
component of the testis was determined as the product of the volume 
density and testis volume. Because the testis density is nearly 1.0 (—1.03- 
4), for subsequent morphometric calculations the testis weight was con­
sidered equal to testis volume (25). To obtain a more precise measure of 
testis volume the testis capsule (—3.4% at 30 d of age and —6.5% at 120 d 
of age) was excluded from the testis weight. The total length of semi­
niferous tubule (meters) was obtained by dividing seminiferous tubule 
volume by the squared radius (R2) of the tubule times the tt value.
Cells count and number
Sertoli cell nucleoli were counted in 10 round or nearly round sem­
iniferous tubule cross-sections, chosen at random, for each animal. These 
counts were corrected for section thickness and nucleoli diameter ac­
cording to Abercrombie (26), as modified by Amann (27). For this pur­
pose, 10 nucleoli diameters were measured for each animal. The total 
number of Sertoli cells was determined from the corrected counts of 
Sertoli cell nucleoli per seminiferous tubule cross-sections and the total 
length of seminiferous tubules according to Hochereau-de Reviers and 
Lincoln (28). The daily sperm production per testis and per gram of testis 
(spermatogenic efficiency) was obtained according to the formula de­
veloped by França (29) as follows: daily sperm production = total 
number of Sertoli cells per testis x the ratio of round spermatids to 
Sertoli cells at stage VII x stage VII relative frequency (percent) /stage 
VII duration (days).
Individual volume of the Leydig cell was obtained from nucleus 
volume and the proportion between nucleus and cytoplasm. The Leydig 
cell nucleus volume was obtained from the knowledge of the mean 
nuclear diameter. For this purpose, 30 nuclei showing evident nucleolus 
were measured at X1000 for each animal. Leydig cell nuclear volume 
was expressed in cubic micrometer and obtained by the formula, 
4/3itR ', where R = nuclear diameter/2. To calculate the proportion 
between nucleus and cytoplasm, a 441-point square lattice was placed
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TABLE 1. Biometric and morphometric data in 30-d-old control and MSG-treated rats (n = 9-10 rats per group; mean ± sem)
“ Statistically significant (P < 0.05 or less).
6 Right organ plus left organ weight divided by two. 
c Testis weight minus tunica albuginea weight.
Parameter Control MSG
Body weight (g) 114 ± 5 92 ± 3"
Total fat mass (g/100 g body weight) 0.51 ± 0.06 1.41 ± 0.10"
Testis weight (mg)6 400 ± 30 230 ± 20"
Testis net weight (mg)c 386 ± 29 222 ± 29"
Gonadosomatic index (%) 0.71 ± 0.03 0.50 ± 0.04"
Epididymis weight (mg)6 46.8 ± 3.5 32.3 ± 1.9"
Adrenal gland weight (mg)6 14.3 ± 0.7 11.2 ± 0.5"
Total length of seminiferous tubule per testis (m) 11.0 ± 0.5 7.4 ± 0.5"
Seminiferous tubules volume density (%) 90 ± 0.9 88.1 ± 0.6
Seminiferous tubules volume (yil) 352 ± 20 194 ± 16"
Tubular lumen volume density (%) 3.4 ± 0.4 2.5 ± 0.2"
Tubular lumen volume (yd) 14 ± 2 6 ± 1“
Germ cell apoptosis volume density (%) 0.0 o.5 ± o.r
Seminiferous tubule diameter (yim) 202 ± 3 182 ± 5"
Leydig cell
Volume density (%) 3.2 ± 0.3 3.3 ± 0.2
Volume in the testis parenchyma (yd) 13.0 ± 1.8 7.2 ± 0.6"
Nuclear diameter (yim) 7.2 ± 0.1 6.8 ± 0.06"
Individual volume (yim3) 819 ± 34 761 ± 25
Cytoplasm volume (yim3) 622 ± 25 599 ± 22
Nucleus volume (yim3) 197 ± 10 163 ± 4"
over the sectioned material at X400 magnification. One thousand points 
over Leydig cells were counted for each animal. The number of Leydig 
cell per testis was estimated from the Leydig cell individual volume and 
the volume occupied by Leydig cell in the testis parenchyma.
Statistical analysis
Data of plasma hormone levels (mean ± sem) were analyzed by 
ANOVA (age x treatment), followed by Fisher's test for comparison of 
different mean values (30). Morphometric data are presented as the
A □ Control■ MSG
B □ Control■ MSG
Fig. 1. Total number of Sertoli (SC) and Leydig cells (LC) per testis 
in 30-d-old and adult Sprague Dawley rats. Observe that at prepu­
bertal age both Sertoli (A) and Leydig cells (B) number per testis are 
significantly lower (P < 0.05) in MSG-treated animals. The numbers 
found for SC and LC for control and MSG-treated rats did not change 
at both ages investigated; however, only the results observed for SC 
showed significant difference (*, P < 0.05) for adult rats.
mean ± sem, and to analyze these data, Student's t test was performed 
using the program STATISTICA for windows (StatSoft, Inc., Tulsa, OK). 
Values for volume densities were subjected to arcsine transformation 
before analyses. Significant differences were considered whenP < 0.05.
Results
Effects of neonatal MSG treatment on testis morphology 
and several endocrine activities in the 30-d-old male rat
The results of biometric and morphometric parameters 
found for control and MSG-treated rats are shown in Table 
1 and Fig. 1 and those of circulating hormone levels in Table 
2. As shown in Table 1, MSG animals showed a significant 
reduction (P < 0.05 or less) in body weight and gonadoso- 
matic index (testis mass divided by body weight), and 
weights of testis, epididymis, and adrenal glands. Similarly, 
these animals showed reduced (P < 0.05 or less) seminiferous 
tubule diameter, seminiferous tubule volume, total length of 
seminiferous tubules, percentage of seminiferous tubule lu­
men and seminiferous tubule lumen volume, Leydig cell 
nuclear volume, and total number of Sertoli and Leydig cells 
per testis (Fig. 1).
Qualitative analysis of the seminiferous tubules showed 
that the pace of germ cells development was slightly delayed 
in treated rats. In this regard, as shown in Fig. 2, the most 
advanced germ cells in control rats was elongated sperma-
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TABLE 2. Hormone plasma levels in 30-d-old control and MSG- 
treated rats (n = 9-10 rats per group; mean ± sem)
Parameter Control MSG
Leptin (ng/ml) 2.41 ± 0.34 8.07 ± 2.19"
Prolactin (ng/ml) 6.79 ± 2.48 2.64 ± 0.58
FSH (ng/ml) 6.96 ± 0.19 3.10 ± 0.29"
LH (ng/ml) 0.31 ± 0.07 0.15 ± 0.02"
FT4 (ng/dl) 1.16 ± 0.05 0.76 ± 0.006"
Testosterone (ng/ml) 3.32 ± 0.47 2.63 ± 0.16"
Corticosterone (yig/dl) 1.84 ± 0.51 4.54 ± 0.97"
“ Statistically significant (P < 0.05 or less).
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Fig. 2. Seminiferous tubules cross-section in 30-d-old Sprague Dawley rats. Observe that in control rats (A), the most advanced germ cells are 
elongated spermatids at step 16 (arrows) present in stages II—III. In hyperleptinemic rats (B), the most advanced germ cells are elongating 
spermatids at step 9 (arrows) present in stages IX-X. Apoptotic pachytene primaiy spermatocytes (arrows) were frequently observed in 
hyperleptinemic animals (C). Toluidine blue staining, X800.
tids at step 16, whereas in hyperleptinemic rats these cells 
were at step 9. In contrast with the control group, in which 
apoptotic germ cells were rarely seen, the percentage of the 
seminiferous epithelium occupied by these cells was 0.5% in 
treated rats (Fig. 2). However, Leydig cell morphology in­
vestigated by light microscopy was apparently normal in 
both groups analyzed (Fig. 3). Sertoli cells looked slightly less 
mature and had significantly reduced nucleoli diameter (1.95 
vs. 1.86; P < 0.04) in MSG-treated rats.
Total fat mass was significantly higher (P < 0.05) in MSG 
than control rats (Table 1). Although the values found for 
prolactin circulating levels in MSG rats represented only 
approximately 40% of the levels observed in controls, this 
difference was, however, not significant (P = 0.09). Regard­
ing several circulating hormones investigated (Table 2), 
whereas leptin and corticosterone levels were 3.5- and 2.5-
Fig. 3. Seminiferous tubule (ST) cross-sections and intertubular 
compartment in control (A) and 30-d-oldhyperleptinemic rats (B). The 
morphology of Leydig cells (arrows) in both groups is, apparently, 
similar. Toluidine blue staining, X800.
fold higher, respectively (P < 0.05), in MSG than control rats; 
conversely, LH, FSH, T, and FT., levels were significantly 
lower (P < 0.05) in MSG than control animals.
Testis structure and function and other phenotypic 
characteristics of the adult. MSG rat
Several phenotypic characteristics of adult, MSG, and 
control, rats are shown in Table 3 and Fig. 1. As described 
in general for young animals, hyperleptinemic (P < 0.05 
vs. control values) rats presented a significant reduction 
(P < 0.05) in body weight and the weights of the epidid­
ymis, seminal vesicle plus coagulating gland, and adrenal 
glands. Careful histological analyses showed that appar­
ently no alteration was observed in seminiferous tubules 
and intertubular compartments of the testis (Fig. 4). How­
ever, similar to 1-month-old rats, detailed stereological 
investigation demonstrated that the number of Sertoli cells 
per testis was approximately 20% lower (P < 0.05) in 
hyperleptinemic animals (Fig. 1). Although not significant, 
a clear trend toward diminution was observed for testis 
weight, Leydig cell individual volume, Leydig cells per 
testis (Fig. 1), and daily sperm production per testis in 
MSG rats. However, very similar results were found for 
most testis parameters evaluated in MSG and control rats, 
such as seminiferous epithelium height, lumen volume, 
germ cells number per tubular cross-section, and Sertoli 
cell efficiency measured as the number of round sperma­
tids per Sertoli cell.
Similar to what was found in young rats, values for total 
fat mass and leptin and corticosterone plasma levels were 
significantly (P < 0.05) higher in MSG than control animals. 
Conversely, circulating LH and FSH levels were significantly 
(P < 0.05) reduced by MSG treatment when compared with, 
day-matched, control values. On the other hand, rats ex­
posed to MSG displayed plasma prolactin, T, and FT4 levels 
within the control range (Table 4).
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TABLE 3. Biometric morphometric data in 120-d-old control and MSG-treated rats (n = 9 rats per group; mean ± sem)
Parameter Control MSG
Body weight (g) 298 ± 12 267 ± 7"
Total fat mass (g/100 g body weight) 2.62 ± 0.24 5.88 ± 0.41"
Testis weight (mg)6 1307 ± 59 1209 ± 61
Testis net weight (mg)' 1222 ± 55 1130 ± 57
Gonadosomatic index (%) 0.87 ± 0.02 0.90 ± 0.05
Adrenal gland weight (mg)6 29.3 ± 1.8 23.9 ± 0.8"
Epididymis weight (mg)6 443 ± 32 361 ± 25"
Seminal vesicle + coagulating gland weight (mg)6 331 ± 29 205 ± 37"
Total length of seminiferous tubule per testis (m) 15.5 ± 0.8 14.3 ± 0.8
Seminiferous tubule volume density (%) 90.0 ± 1.2 92.4 ± 0.5
Seminiferous tubule volume (ml) 1.09 ± 0.04 1.03 ± 0.05
Tubular lumen volume density (%) 8.0 ± 1.0 8.0 ± 1.1
Tubular lumen volume (ml) 0.10 ± 0.02 0.09 ± 0.01
Seminiferous tubule diameter (yim) 299 ± 4 310 ± 7
Sertoli cell efficiency 11.1 ± 0.8 12.0 ± 0.5
Leydig cell
Volume density (%) 1.4 ± 0.2 1.0 ± 0.2
Volume in the testis parenchyma (yil) 17.0 ± 3 11 ± 2
Nuclear diameter (yim) 8.2 ± 0.3 7.7 ± 0.2
Individual volume (yim3) 1207 ± 107 966 ± 66
Cytoplasm volume (yim3) 914 ± 84 724 ± 53
Nucleus volume (yim3) 293 ± 24 242 ± 13
Daily sperm production per testis (X106) 34.2 ± 1.8 30.0 ± 2.1
“ Statistically significant (P < 0.05 or less).
6 Right organ plus left organ weight divided by two. 
c Testis weight minus tunica albuginea weight.
Discussion
To our knowledge, the present work is the first study 
investigating the male reproductive tract structure and func­
tion over development in hypothalamo-damaged rats due to 
neonatal MSG treatment. The increased circulating levels of 
leptin and corticosterone and the hyperadiposity developed 
by MSG-treated rats confirm the effectiveness of the treat­
ment with this neurotoxin (31). Also, other hormonal alter­
ations characterized the prepubertal MSG male rat, such as 
decreased gonadotropins, androgen, and thyroid hormone 
levels (16,17). Although still controversial (32,33), we found 
no significant changes in circulating prolactin levels, a hor­
mone directly implicated in testis development (34). More­
over, in MSG rats, a clear hyperprolactinemia has been found 
in female but not male rats, thus suggesting a clear sexual 
dimorphism of the neurotoxic effect on dopaminergic-lac- 
totrope function (35). Our results clearly indicate that neo­
natal MSG treatment-induced alteration in several HPG axis 
parameters examined at age 30 d; however, at adulthood, 
some of them resulted normalized.
As in most mammalian species, the normal rat postnatal 
testis development can be divided in two, distinct and in­
versely correlated, phases (36,37). In the first, which lasts up 
to approximately 2 wk after birth, extensive spermatogonial 
and Sertoli cell proliferation can be observed, in turn pro­
moting the growth in length of seminiferous cords, whereas 
during the second phase, that takes place from approxi­
mately 2 to 7-8 wk after birth, a noticeable increase in the 
numbers of germ cells and adult-type Leydig cells take place 
(36-38), and a dramatic growth in testis size, Sertoli cell fluid 
secretion, and tubular diameter can also be observed. These 
two phases are regulated by specific and different hormones 
and growth factors (36, 38). For instance, FSH and thyroid 
hormones are considered the main regulators of Sertoli cell 
proliferation and differentiation (36,39,40), respectively. On 
the other hand, several hormones and growth factors, such 
as thyroid hormones, LH, steroids, anti-Mullerian hormone, 
platelet-derived growth factor-A, TGFa/¡3, IGF-I, and cyto­
kines secreted by macrophages, are responsible for the reg­
ulation of Leydig cell proliferation and differentiation (38). In 
general, the factors related to proliferation and differentia­
tion of germ cells are secreted by Sertoli cells, mainly under 
the influence of androgens and FSH (41, 42). Also, complex 
interaction between the seminiferous and interstitial com­
partments of the testis takes place during testis development, 
allowing the testis to fulfill both its endocrine and exocrine 
functions (36, 37, 43, 44).
Several of the above-mentioned factors were significantly 
reduced in MSG-treated rats investigated at 30 d of age, and, 
at least in part, these alterations might explain the results 
found in the present work, mainly for testis structure and 
function. Unpublished data, from ongoing experiments be­
ing developed in our laboratories, indicate that at 2 wk after 
birth, MSG-treated rats are already hyperleptinemic. At this 
stage of development, the levels of FSH, LH, and thyroid 
hormones, but not prolactin, are already decreased in these 
rats; thus, we could expect lower proliferation rate of Sertoli 
and Leydig cells as well as reduced functional activity of 
these cell populations. It should be mentioned that although 
not measured by us, it is possible that the conversion of T into 
estradiol (adipose aromatase activity) could be playing a role 
on delayed Leydig cell development and function in MSG 
rats (45). In this regard, the results found for the more im­
mature status of Sertoli cells and significantly reduced Ley­
dig cell nuclear volume and testosterone secretion, observed 
in 30-d-old MSG rats, would confirm this assumption. These 
results probably reflect the significantly lower seminiferous 
tubule volume and tubular lumen volume observed in pre-
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Fig. 4. Panoramic view of the testis structure in control (A) and 
hyperleptinemic adult rats (B). Observe that the testis structure is 
apparently normal in treated animals. Toluidine blue staining, x 100.
pubertal MSG-treated rats. Also, because thyroid hormone 
receptors are present in Sertoli and germ cells (46, 47), par­
ticularly from intermediate spermatogonia to midcycle 
pachytene, being responsible for their differentiation, the 
findings related to increased apoptotic germ cells and the less 
mature Sertoli cells status in prepubertal treated rats might 
be correlated with lower free thyroxin levels. Combined to 
lower FT4 levels, the results found for the more immature 
status of Sertoli cells suggest that the proliferative activity of 
this cell was slightly extended (40). In this regard, we could 
expect a much lower testis size and number of Sertoli cells 
per testis due to MSG treatment and the associated dimin­
ished FSH plasma levels. Corroborating this hypothesis, on­
going studies in our laboratory (48) show that in postnatal 
hypothyroidic condition (due to postnatal propylthiouracil
TABLE 4. Hormone plasma levels in 120-d-old control and MSG- 
treated rats (n = 9 rats per group; mean ± sem)
“ Statistically significant (P < 0.05 or less).
Parameter Control MSG
Leptin (ng/ml) 7.26 ± 1.61 27.04 ± 5.9"
Prolactin (ng/ml) 7.16 ± 2.77 5.28 ± 2.81
FSH (ng/ml) 4.92 ± 0.40 3.13 ± 0.28"
LH (ng/ml) 0.38 ± 0.07 0.19 ± 0.02"
FT4 (ng/dl) 1.20 ± 0.09 1.11 ± 0.01
Testosterone (ng/ml) 4.58 ± 0.58 4.77 ± 0.78
Corticosterone (yig/dl) 4.67 ± 0.95 8.81 ± 1.24"
treatment that also decreases FSH plasma levels) daily FSH 
injections, during 3 wk after birth, has an additive effect on 
Sertoli cells number per testis.
Because leptin receptors are found in both tubular and 
intertubular compartments of the testis (10, 49), we cannot 
exclude a direct effect of hyperleptinemia on Sertoli, Leydig, 
and germ cell functions and development. Dihydrotestos­
terone, originated by 5a-reductase-mediated T metabolism, 
is important for epididymal function (50, 51). In this regard, 
the significantly reduced epididymis weight observed in 
MSG-treated rats might be correlated with lower T levels 
found in these animals. The diminution observed in the 
weight of the adrenal glands tallies with previous published 
data (52), suggesting that changes in adrenal cortex size/ 
morphology are symptomatic of trophic stimulation. As ex­
pected, FSH and LH plasma levels were altered in adult MSG 
rats, indicating a permanent ARC lesion in these animals (53). 
Our data, in agreement with previous observations, indicate 
that thyroid hormone (54) and testosterone (19) plasma levels 
were similar in 120-d-old control and MSG male rats.
It is worth mentioning that data obtained in the present 
investigation for structural and functional parameters in con­
trol adult rats, including data for Leydig cells, are in the range 
of data presented for rats in the literature [see review in 
Russell and Franca (55) and Refs. 56 and 57]. Except for the 
number of Sertoli cells per testis, the values obtained for the 
parameters related to seminiferous tubules were similar in 
control and MSG-treated adult rats. These findings indicate 
that alterations due to MSG treatment and hyperleptinemia, 
related to Sertoli cell function and the spermatogenic process, 
can be reversed at the adult age. Nevertheless, because usu­
ally the Sertoli cell proliferative activity does not extend 
beyond 2-3 wk after birth (36, 39), the final number of these 
cells per testis remained low after 30 d of age in MSG rats.
Because the Sertoli cell can support a limited and species­
specific number of germ cells, it is already well known in the 
literature that the number of Sertoli cells, established during 
the prepubertal period, determines the final testis size and 
the magnitude of sperm production in sexually mature an­
imals (58-61). In this regard, based on the number of Sertoli 
cells per testis, one could expect a low daily sperm produc­
tion per testis (spermatogenic efficiency) in adult MSG rats. 
However, usually experimental conditions in which the 
number of Sertoli cells per testis is decreased or increased 
would lead, respectively, to high (Franca, L. R., and J. R. 
Miranda, unpublished data) or low (45, 62) number of germ 
cells per each Sertoli cell (named Sertoli cell efficiency). In 
fact, although not significantly different, compared with con­
trols, Sertoli efficiency in MSG rats is almost 10% higher, and 
this result probably explains why the values found for sper­
matogenic efficiency are similar in both groups. Paradoxi­
cally, different from data found in the present study, in the 
condition of reduced Sertoli cells number per testis, one 
should expect higher FSH levels (59). Although not fully 
understood, the disturbed HPG axis due to MSG treatment 
would probably shadows the scenario and the real signifi­
cance of reduced FSH plasma levels observed in the present 
model, we also cannot exclude that the evaluation of inhibin 
B levels in MSG rats could provide additional information 
regarding Sertoli cell function.
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Although several parameters related to Leydig cell func­
tion, such as Leydig cell individual volume and the volume 
occupied by this cell in the intertubular compartment, 
showed a clear trend toward diminution in hyperleptinemic 
adult rats, T plasma levels remained normal. The decreased 
weights of sexual accessory organs observed in hyperlep­
tinemic adult rats, even in the presence of normal T levels, 
probably resulted from decreased Leydig cell steroidogenic 
activity during the critical period of organ development. 
Also, because these organs are androgen dependent (50, 51, 
63), disturbance in the conversion of T in dihydrotestoster­
one, as well as a direct effect of leptin on the testis of the MSG 
rat, cannot be excluded.
Recent studies developed by our research group showed 
that MSG-treated rats displayed an in vitro Leydig cell dys­
function when exposed to graded concentrations of human 
chorionic gonadotropin (19). It was also suggested in this 
study that, in normal rat testes, leptin may represent an 
additional inhibitory factor of rat testicular steroidogenesis 
(P450 side-chain cleavage enzyme, steroidogenic acute reg­
ulatory protein, and 17/3-hydroxysteroid dehydrogenase). 
Besides that, neurotoxin-elicited chronic hyperleptinemia 
could be responsible for down-regulation of testicular 
mRNA Ob-Rb expression at adult age (19). However, 
because MSG animals early develop hyperadiposity/hyper- 
leptinemia, probably as a consequence of enhanced corti- 
coadrenal activity (64), a clearly recognized adipocyte­
stimulating signal, it remains to be determined whether the 
hypothalamic lesion itself or in association with changes in 
adrenal-adipocyte cross-talk is a determinant factor for im­
paired fertility of the MSG male rat (65). In fact, it should be 
considered that corticoadrenal hyperactivity could be di­
rectly involved in reducing hypothalamic (LHRH)-gonado- 
trope (LH) (66) axis activity, thus resulting in an inappro­
priate sexual maturation (67) of the MSG male rat. It remains 
to be determined whether the correction of hypercorticoste- 
ronemia, in MSG rats and, because it occurred for the hy­
peradipose phenotype (64), could avoid impaired male re­
productive function. Recent unpublished data from our 
laboratory indicate that the reduction of circulating glucocor­
ticoid and leptin levels, due to bilateral adrenal enucleation 
for 21 d in adult MSG rats, restored the inhibitory effect of 
exogenous leptin on human chorionic gonadotropin-stimu­
lated T production by isolated Leydig cells. Moreover, to 
better understand the fine mechanisms related to our find­
ings on impaired reproductivity characterizing MSG rats, 
studies in chronic hyperleptinemic rats, due to daily exog­
enous leptin administration over development, are currently 
running.
In conclusion, our results indicate that MSG animals dis­
play the following HPG axis-altered characteristics: 1) dis­
turbed Sertoli and Leydig cell proliferation over testis de­
velopment; 2) diminished Sertoli cell number, the only 
tubular element already compromised before puberty; and 3) 
decreased weights of sexual accessory organs, at both ages 
investigated, which probably resulted from lower Leydig cell 
steroidogenic activity during the critical period of organ 
development. It remains to be determined whether long­
term hyperleptinemia is a main factor for disrupted HPG axis 
development in the MSG male rat.
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